glp-1/gip dual agonist lilly The FDA approved a new GLP-1 pill for weight loss from Eli on Wednesday. The drug, called Foundayo, is the second GLP-1 weight-loss pill. CBS News' @DrLaPook has more on the new medication Triple Agonism Based Therapies for
Description
Additionally, treatment with Liraglutide was associated with reduced mean baseline urinary sodium, extracellular volume, natriuresis, N-terminal pro b-type natriuretic peptide (NT-proBNP) and urinary albumin excretion rate, all of which are indicative of its beneficial effects on renal function [87]
eClinicalMedicine 37:100895
Indeed, by comparing the high-dose liraglutide therapy (3.0 mg/day) with the combination therapy (metformin 1000 mg BID + liraglutide 1.2 mg/day), Jensterle et al
You still want to have a slow, steady weight loss with slow dose titration
The biological evaluation of the newly synthesized chemical agents demonstrated that molecule 63 possesses the most potent enzyme inhibition activity, with an IC 50 of 17.7 M (Figure 7)
It is not a price cut
